News Agencies Feed

healthcare

Jun 27

Takeda and Seattle Genetics Announce Positive Results from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma

Takeda and Seattle Genetics Announce Positive Results from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma

(ME NewsWire)-- Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that the Phase 3 ECHELON-1 clinical trial met its primary endpoint of a statistically significant improvement in modified progression-free survival (PFS) versus the control arm. ECHELON-1 is a randomized, multicenter trial evaluating ADCETRIS (brentuximab vedotin) as part of a frontline combination chemotherapy regimen in 1,334 patients with previously untreated advanced classical Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed to CD30, a defining marker of classical Hodgkin lymphoma. ADCETRIS is......

Continue Reading >>

Jun 24

Children's Heart Center at AUBMC makes history by performing first successful heart transplant in Lebanon in the pediatric age group

The Children's Heart Center (CHC) at the American University of Beirut Medical Center (AUBMC) joined the elite heart centers in the world by performing its first successful heart transplant for a pediatric patient in Lebanon. The child was 5 years of age. A few days later, the patient"...

Continue Reading >>

Jun 24

Acelity Strengthens Global Commercial Leadership; Names Ramesh Subrahmanian President for International Region 

Acelity Strengthens Global Commercial Leadership; Names Ramesh Subrahmanian President for International Region 

(ME NewsWire)-- Acelity L.P. Inc., a leading global advanced wound care company, today announced Ramesh Subrahmanian will join the company as President for the International region and member of the senior leadership team effective July 17th. Acelity"...

Continue Reading >>

Jun 24

Takeda Presents Data from Phase 1/2 Studies for NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma Patients and in the Maintenance Setting

Takeda Presents Data from Phase 1/2 Studies for NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma Patients and in the Maintenance Setting

– Early studies of weekly and twice-weekly ixazomib plus lenalidomide and dexamethasone demonstrate deep responses after induction, with deepening responses seen after single-agent ixazomib maintenance –

–"...

Continue Reading >>

Jun 23

Hasbani, Italy envoy launch health equipment

Deputy Prime Minister and Health Minister Ghassan Hasbani inaugurated an X-ray blood irradiator at the Rafik Hariri University Hospital in Beirut Thursday, alongside Italian Ambassador to Lebanon Massimo Marotti. “The support to Lebanese public health is one of our flagship cooperation"...

Continue Reading >>

Jun 20

Lebanon’s dumping of toxic garbage into the Mediterranean stinks of EU corruption

The EU’s farcical ‘foreign policy’ in the Middle East is failing in Lebanon, where dumping toxic garbage into the Mediterranean Sea is creating a massive threat to the entire planet. But what’s the link with Syria’s refugees?

Recently,"...

Continue Reading >>

Jun 20

First-Ever World Kidney Cancer Q&A Day Highlights Growing Global Burden

First-Ever World Kidney Cancer Q&A Day Highlights Growing Global Burden

(ME NewsWire)-- Kidney cancer is a silent disease that’s on the rise. The global incidence of kidney cancer is predicted to increase by a shocking 22 percent by 2020. Explanations are incomplete, but include risk factors such as aging, obesity,"...

Continue Reading >>

Jun 20

New Study Compares Performance of Masimo Next Generation SedLine® Patient State Index (PSi) to Original PSi During Anesthesia

New Study Compares Performance of Masimo Next Generation SedLine® Patient State Index (PSi) to Original PSi During Anesthesia

(ME NewsWire)-- Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at Euroanaesthesia 2017 in Geneva, Switzerland. In the study, researchers at University Medical Center Groningen, Netherlands, compared original and Next Generation versions of Masimo Patient State Index (PSi, a processed EEG parameter related to the effect of anesthetic agents) during Masimo SedLine® brain function monitoring of patients under propofol and sevoflurane anesthesia.1 SedLine brain function monitoring features four simultaneous EEG leads to enable continuous assessment of both sides of the brain, four EEG waveforms, a Density Spectral......

Continue Reading >>

Jun 19

Lebanon Leads the Pack in Closing the Tech Industry’s Gender Gap

The tech sector is notoriously male-dominated. This is ever apparent in Silicon Valley in the U.S., a country where women make up 59 percent of the workforce, but only hold 30 percent of jobs in the tech industry. This disconnect is keeping the industry back, but it doesn’t exist"...

Continue Reading >>

Jun 17

Health Ministry Confiscates 2600 Boxes of Smuggled Medicines in North Clinic

Police on Friday confiscated hundreds of smuggled medicinal products and sealed with red wax a specialized clinic center in the northern region of Bhannine, LBCI reported on Friday.

A team from the Health Ministry"...

Continue Reading >>